JIGZX
Price
$80.15
Change
-$0.95 (-1.17%)
Updated
Jun 13 closing price
Net Assets
1.82B
RGEBX
Price
$74.89
Change
-$0.91 (-1.20%)
Updated
Jun 13 closing price
Net Assets
306.22B
Interact to see
Advertisement

JIGZX vs RGEBX

Header iconJIGZX vs RGEBX Comparison
Open Charts JIGZX vs RGEBXBanner chart's image
JPMorgan U.S. GARP Equity R2
Price$80.15
Change-$0.95 (-1.17%)
VolumeN/A
Net Assets1.82B
American Funds Growth Fund of Amer R2E
Price$74.89
Change-$0.91 (-1.20%)
VolumeN/A
Net Assets306.22B
JIGZX vs RGEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JIGZX vs. RGEBX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JIGZX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 306B vs. JIGZX (1.83B). JIGZX (0.00) and RGEBX (0.00) have matching dividends . JIGZX was incepted earlier than RGEBX: JIGZX (17 years) vs RGEBX (11 years). JIGZX (1.19) is less costly to investors than RGEBX (1.09). JIGZX is a more actively managed with annual turnover of: 46.00 vs. RGEBX (25.00). JIGZX has a lower initial minimum investment than RGEBX: JIGZX (0) vs RGEBX (250). RGEBX annual gain was more profitable for investors over the last year : 7.68 vs. JIGZX (5.77). JIGZX return over 5 years is better than : 49.51 vs. RGEBX (45.42).
JIGZXRGEBXJIGZX / RGEBX
Total Expense Ratio1.091.09100%
Annual Report Gross Expense Ratio1.191.09109%
Fund Existence17 years11 years-
Gain YTD1.2124.82925%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.83B306B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year5.777.6875%
Returns for 3 years71.5551.01140%
Returns for 5 years49.5145.42109%
Returns for 10 years99.3765.87151%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APGE44.482.62
+6.26%
Apogee Therapeutics
VVOS2.140.01
+0.47%
Vivos Therapeutics
SJM95.72-1.65
-1.69%
JM Smucker Company (The)
ELVA3.38-0.17
-4.79%
Electrovaya
NNDM1.44-0.12
-7.69%
Nano Dimension Ltd